N-[[[4-[[[[(4-Chlorophenyl)cyclopropylmethylene]amino]oxy]methyl]phenyl]amino]carbonyl]-2,6-difluorobenzamide

CAS : 113036-88-7

Ref. 3D-FC173210

Informations sur le produit

• Nom: N-[[[4-[[[[(4-Chlorophenyl)cyclopropylmethylene]amino]oxy]methyl]phenyl]amino]carbonyl]-2,6-difluorobenzamide
• Synonymes: 1-[Α-(4-Chloro-Α-Cyclopropylbenzylideneaminooxy)-P-Tolyl]-3-(2,6-Difluorobenzoyl)Urea, A 1335, Andalin, Andalin DC 25, Benzamide, N-(((4-(((((4-Chlorophenyl)Cyclopropylmethylene)Amino)Oxy)Methyl)Phe, Benzamide, N-[[[4-[[[[(4-chlorophenyl)cyclopropylmethylene]amino]oxy]methyl]phenyl]amino]carbonyl]-2,6-difluoro-, Du 319722, Flucycloxuron, N-({4-[({[(1E)-(4-chlorophenyl)(cyclopropyl)methylidene]amino}oxy)methyl]phenyl}carbamoyl)-2,6-difluorobenzamide, N-({4-[({[(4-Chlorophenyl)(cyclopropyl)methylene]amino}oxy)methyl]phenyl}carbamoyl)-2,6-difluorobenzamide, Oms 3041, Ph 70-23, Ubi-A 1335

Description

4-Chloro-N-[(2,6-difluorobenzoyl)amino]benzamide is a compound that inhibits the synthesis of bacterial proteins. It is a potent inhibitor of gamma-aminobutyric acid (GABA) transaminase and exhibits synergistic effects with other GABA transaminase inhibitors. The mechanism of action of 4-chloro-N-[(2,6-difluorobenzoyl)amino]benzamide is not well understood, but it may involve inhibition of the enzyme activities involved in protein synthesis in bacteria. 4-Chloro-N-[(2,6-difluorobenzoyl)amino]benzamide has been shown to inhibit mitochondrial cytochrome c oxidase and the fatty acid synthase system in bacteria. This drug also has an analytical method for detection and quantification by HPLC/UV.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 483.89 g/mol
• Formule: C₂₅H₂₀ClF₂N₃O₃
• Degré de pureté: Min. 95%